Trials / Completed
CompletedNCT03244514
Biomarker-guided Implementation of the AKI Bundle
Biomarker-guided Implementation of the Cardiovascular (CV) Surgery AKI Bundle to Reduce the Occurrence of AKI After Cardiac Surgery- Prevention of AKI
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (actual)
- Sponsor
- University Hospital Muenster · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury. The investigators hypothesize that the implementation of a bundle of supportive measures adapted to patients undergoing cardiovascular surgery reduces the occurence of AKI. A Randomized prospective multicenter trial is needed to investigate whether the implementation of the bundle of measures is effective to prevent AKI in high risk patients undergoing cardiac surgery. In this feasibility trial the investigators will analyze the compliance rate to the trial protocol in a multicenter, multinational cohort in preparation for a large randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intervention | Implementation of the cardiovascular AKI bundle (see arm description) |
Timeline
- Start date
- 2017-11-02
- Primary completion
- 2019-10-26
- Completion
- 2020-01-26
- First posted
- 2017-08-09
- Last updated
- 2020-02-19
Locations
12 sites across 5 countries: Belgium, Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03244514. Inclusion in this directory is not an endorsement.